Loading clinical trials...
Loading clinical trials...
A 24-week Two-armed Proof-of-concept Exploratory Analysis of Subcutaneous Ixekizumab Administration in Patients With Recalcitrant Non-infectious Intermediate, Posterior, Panuveitis, or Chronic Steroid-dependent Anterior Uveitis.
Conditions
Interventions
Ixekizumab Prefilled Syringe
Locations
1
United States
Massachusetts Eye Research and Surgery Institution
Waltham, Massachusetts, United States
Start Date
June 1, 2022
Primary Completion Date
December 30, 2024
Completion Date
December 30, 2024
Last Updated
October 16, 2023
NCT05486468
NCT06431373
NCT07262437
NCT05101928
NCT03097315
NCT02952001
Lead Sponsor
Massachusetts Eye Research and Surgery Institution
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions